ISPE’s Pharmaceutical Engineering explores how agentic AI could reshape enterprise asset management in life sciences. The article highlights Blue Mountain’s vision for human-in-the-loop AI—moving beyond predictive maintenance toward autonomous workflows that recommend, act, and continuously learn, while maintaining GMP compliance and audit readiness. It frames agentic AI not as a replacement for experts, but as a partner in decision-making, unlocking efficiency and risk reduction across regulated operations